Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Put resources into Lab Precious stones - 2Geminid meteor shower, one of the year's most reliable, peaks this weekend
- 3‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- 4Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- 5From a new flagship space telescope to lunar exploration, global cooperation – and competition – will make 2026 an exciting year for space
- Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- Strength training is crucial after menopause. How to make the most of your workouts
- Famous Network programs in Europe and America
- Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
- Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- Vote in favor of your #1 Sort of Convenience for a Family
- ‘Everybody Loves Raymond: 30th Anniversary Reunion’ premiere date: How to watch, channel, time, cast and more
- Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
